Efficacy and safety of transjugular intrahepatic portosystemic shunt versus endoscopic variceal ligation for variceal rebleeding: a systematic review and meta-analysis
- PMID: 40337405
- PMCID: PMC12055141
- DOI: 10.1097/MS9.0000000000003215
Efficacy and safety of transjugular intrahepatic portosystemic shunt versus endoscopic variceal ligation for variceal rebleeding: a systematic review and meta-analysis
Abstract
Background: Variceal bleeding is a significant cause of morbidity and mortality among patients with cirrhosis. While both transjugular intrahepatic portosystemic shunt (TIPS) and endoscopic variceal ligation (EVL) are utilized for variceal rebleeding prevention, their comparative efficacy and safety remain debated.
Methods: A systematic review and meta-analysis were conducted to compare TIPS with EVL for variceal rebleeding prevention. A comprehensive search of electronic databases on PubMed, Embase, Scopus, and Web of Science identified 16 studies meeting inclusion criteria. Data on outcomes including gastrointestinal bleeding, variceal rebleeding, hepatic encephalopathy, treatment failure, and mortality were extracted and analyzed.
Results: TIPS was associated with significantly lower rates of gastrointestinal bleeding (RR = -0.69, 95% CI [-0.92, -0.47], P < 0.001), variceal rebleeding (RR: -0.99, 95% CI [-1.2, -0.79], P < 0.001), and bleeding from banding ulcers (RR: -1.51, 95% CI [-2.75, -0.27], P = 0.02) compared to EVL. However, TIPS was linked to higher rates of hepatic encephalopathy (RR: 0.44, 95% CI [0.18, 0.71], P < 0.001) and treatment failure (RR: -1.29, 95% CI [-2.01, -0.57], P < 0.001). No significant differences were found in mortality, liver failure, hepatocellular carcinoma, or other clinical outcomes between the two interventions.
Conclusion: TIPS demonstrates superiority over EVL in reducing variceal rebleeding and gastrointestinal bleeding. However, it is associated with higher rates of hepatic encephalopathy and treatment failure. Individualized treatment decisions should consider patient characteristics and treatment goals to optimize outcomes in variceal bleeding management. Further research is warranted to refine treatment strategies and minimize adverse events associated with both interventions.
Keywords: EVL; TIPS; cirrhosis; endoscopic variceal ligation; meta-analysis; transjugular intrahepatic portosystemic shunt; variceal bleeding.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. The authors declare no conflicts of interest related to this work.
Figures
Similar articles
-
Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials.Oncotarget. 2017 May 24;8(34):57399-57408. doi: 10.18632/oncotarget.18143. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915680 Free PMC article.
-
Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.Radiology. 2023 Aug;308(2):e223201. doi: 10.1148/radiol.223201. Radiology. 2023. PMID: 37606572 Clinical Trial.
-
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD001023. doi: 10.1002/14651858.CD001023.pub3. Cochrane Database Syst Rev. 2018. PMID: 30378107 Free PMC article.
-
Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.Hepatol Int. 2022 Dec;16(6):1379-1389. doi: 10.1007/s12072-022-10388-7. Epub 2022 Oct 18. Hepatol Int. 2022. PMID: 36255564 Clinical Trial.
-
Comparative outcome of transjugular intrahepatic portosystemic shunt with or without variceal obliteration: a systematic review and meta-analysis.Abdom Radiol (NY). 2023 Apr;48(4):1429-1437. doi: 10.1007/s00261-023-03843-y. Epub 2023 Feb 23. Abdom Radiol (NY). 2023. PMID: 36821005
References
-
- Ebada H, Ebrahim A, Elbareedy A, et al. . Novel score for prediction of esophageal varices in HCV- related chronic liver disease patients. Afro-Egypt J Infect Enem Dis 2021;11:5.
-
- Lin L.L, Du S-M, Fu Y, et al. . Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials. Oncotarget 2017;8:57399–408. - PMC - PubMed
LinkOut - more resources
Full Text Sources